Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4632]

NICE gives go ahead to ipilimumab for advanced melanoma

NICE gives go ahead to ipilimumab for advanced melanoma

ESMO 2012: Most cancer patients prepared to delay treatment to benefit from personalised care

ESMO 2012: Most cancer patients prepared to delay treatment to benefit from personalised care

Personalised medicine promises radical improvements to European healthcare

Personalised medicine promises radical improvements to European healthcare

Phase 3 trial confirms abiraterone acetate efficacy for patients with advanced prostate cancer

Phase 3 trial confirms abiraterone acetate efficacy for patients with advanced prostate cancer

Study highlights potential drug target for one in ten breast cancers

Study highlights potential drug target for one in ten breast cancers

Epigenetic drug discovery collaboration

Epigenetic drug discovery collaboration

Dabrafenib offers improved progression-free survival for melanoma patients

Dabrafenib offers improved progression-free survival for melanoma patients

Experimental combination for stomach and oesophageal cancer

Experimental combination for stomach and oesophageal cancer

ASCO 2012: New quality measures tested to encourage better taking of family histories and referral to genetic counseling

ASCO 2012: New quality measures tested to encourage better taking of family histories and referral to genetic...

ASCO 2012: Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours, particularly those with chromosomal mutations

ASCO 2012: Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours...

More from ecancer